pyrazines has been researched along with xanomeline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bymaster, FP; Calligaro, DO; Deeter, JB; Merritt, L; Mitch, CH; Olesen, PH; Peters, SC; Sauerberg, P; Sawyer, BD; Shannon, HE; Sheardown, MJ; Swedberg, MD; Ward, JS | 1 |
Abou-Gharbia, M; Boast, CA; Husbands, GM; Moyer, JA; Sabb, AL; Stein, RP; Tasse, RP; Tokolics, J | 1 |
Abou-Gharbia, M; Bartolomeo, AC; Boast, CA; Buccafusco, JJ; Husbands, MG; Kille, N; Morris, H; Moyer, JA; Rosenzweig-Lipson, S; Sabb, AL | 1 |
3 other study(ies) available for pyrazines and xanomeline
Article | Year |
---|---|
Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles.
Topics: Animals; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Male; Mice; Muscarinic Agonists; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Structure-Activity Relationship; Thiadiazoles | 1995 |
Discovery of a highly potent, functionally-selective muscarinic M1 agonist, WAY-132983 using rational drug design and receptor modelling.
Topics: Administration, Oral; Animals; Bridged-Ring Compounds; Carbachol; Cerebral Cortex; CHO Cells; Cognition Disorders; Computer Simulation; Cricetinae; Crystallography, X-Ray; Drug Design; Drug Evaluation, Preclinical; Humans; Macaca mulatta; Maze Learning; Models, Molecular; Muscarinic Agonists; Phosphatidylinositols; Protein Conformation; Pyrazines; Pyridines; Rats; Receptor, Muscarinic M1; Receptors, Muscarinic; Salivation; Structure-Activity Relationship; Thiadiazoles | 1999 |
The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist.
Topics: Animals; Aziridines; Behavior, Animal; Brain; Bridged-Ring Compounds; Choline; Choline O-Acetyltransferase; Cognition; Dose-Response Relationship, Drug; Drug Interactions; Female; Frontal Lobe; Hippocampus; Hypothermia; Macaca mulatta; Male; Mice; Muscarinic Agonists; Neuromuscular Blocking Agents; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Salivation; Scopolamine; Thiadiazoles; Time Factors; Visual Cortex | 2000 |